The effect of salmeterol and salbutamol on mediator release and skin responses in immediate and late phase allergic cutaneous reactions

Inflammation Research

Volumn 48, Issue 10, 1999, Pages 527-532

  Petersen, L J ^a   Skov, P S ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Beta adrenergic agonists; Immediate type hypersensitivity; Inflammatory mediators; Leucocyte chemotaxis; Skin

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CODEINE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; MYELOPEROXIDASE; PROSTAGLANDIN D2; SALBUTAMOL; SALMETEROL; TRYPTASE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; HISTAMINE RELEASE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTRADERMAL DRUG ADMINISTRATION; MALE; MEDIATOR RELEASE; SKIN ALLERGY; URTICARIA;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ALLERGENS; DERMATITIS, ALLERGIC CONTACT; FEMALE; HISTAMINE; HUMANS; INFLAMMATION MEDIATORS; MALE; POACEAE; POLLEN; PROSTAGLANDIN D2; REGRESSION ANALYSIS; SKIN TESTS; TIME FACTORS;

EID: 0032697991     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050498     Document Type: Article

References (31)

1. Svedmyr N, Löfdahl CG. The use of beta 2-adrenoceptor agonists in the treatment of bronchial asthma. Pharmacol Toxicol 1996; 78: 3-11.
2. Okayama Y, Church MK. Drugs modifying the responses of mast cells and basophils. In: Foreman JC, editor. Immunopharmacology of Mast Cells and Basophils. London: Academic Press, 1993: 139-52.
3. Martin GL, Atkins PC, Dunsky EH, Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol 1980; 66: 204-12.
4. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 1985; 132: 986-92.
5. 2-adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43: 674-8.
6. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991; 104: 672-6.
7. Johnson M. Beta 2-agonists as anti-inflammatory therapies in the lung. Agents Actions 1993; 41: 27-45.
8. Whelan CJ, Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 1992; 105: 831-8.
9. Bradding P. Anti-inflammatory effects of long-acting β-agonists in asthma. Clin Exp Allergy 1995; 25: 912-4.
10. Grönneberg R, Zetterstrom O. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions. Clin Exp Allergy 1992; 22: 257-63.
11. Ottonello L, Morone P, Dapino P, Dallegri F. Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils. Clin Exp lmmunol 1996; 106: 97-102.
12. Anderson R, Feldman C, Theron AJ, Ramafi G, Cole PJ, Wilson R. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro. Br J Pharmacol 1996; 117: 1387-94.
13. Ezeamuzie CI, al-Hage M. Differential effects of salbutamol and salmeterol on human eosinophil responses. J Pharmacol Exp Ther 1998; 284: 25-31.
14. Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995; 99: 461-6.
15. Charlesworth EN. The skin as a model to study the pathogenesis of IgE-mediated acute and late-phase responses. J Allergy Clin Immunol 1994; 94: 1240-50.
16. Zweiman B. Skin chamber techniques. In: Serup J, Jemec GBE, editors. Handbok of Non-invasive Methods and the Skin. Boca Raton: CRC Press, 1995: 633-9.
17. Ting S, Zweiman B, Lavker R. Terbutaline modulation of human allergic skin reactions. J Allergy Clin Immunol 1983; 71: 437-41.
18. Grönneberg R, Strandberg K, Hägermark Ö. Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents Allergy 1980; 35: 409-12.
19. Whelan CJ, Johnson M, Vardey CJ. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guineapig skin and lung. Br J Pharmacol 1993; 110: 613-8.
20. Grönneberg R, Zetterström O. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 1. Dose-response relation and duration of effect on the early wheal and flare response. Allergy 1990; 45: 334-9.
21. Grönneberg R, Raud J. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late phase induration in human skin. Allergy 1996; 51: 685-92.
22. Grönneberg R, van Hage-Hamsten M, Halldén G, Hed J, Raud J. Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients. Allergy 1996; 51: 640-6.
23. Proud D, Reynolds CJ, Lichtenstein LM, Kagey Sobotka A, Togias A. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 1998; 28: 868-75
24. Petersen LJ, Poulsen LK, Søndergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994; 94: 773-83.
25. Petersen LJ. Measurement of histamine release in intact human skin in vivo by microdialysis technique. Clinical and experimental findings. Doctoral thesis, University of Copenhagen, Denmark. Dan Med Bull 1998; 45: 383-401.
26. Grönneberg R, Strandberg K, Hägermark Ö. Effect of terbutaline, a beta 2-adrenergic receptor stimulating compound, on cutaneous responses to histamine, allergen, compound 48/80, and trypsin. Allergy 1979; 34: 303-9.
27. Grönneberg R, Dahlén SE. Interactions between histamine and prostanoids in IgE-dependent, late cutaneous reactions in man. J Allergy Clin Immunol 1990; 85: 843-52.
28. Charlesworth EN, Hood AF, Soler NA, Kagey Sobotka A, Norman PS, Lichtenstein I.M. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83: 1519-26.
29. Frew AJ, Varney VA, Gaga M, Kay AB. Immunohistology of human allergic late-phase skin reactions. Skin Pharmacol 1991; Suppl 1: 71-8.
30. Zweiman B, Kaplan AP, Tong L, Moskovitz AR. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997; 100: 104-9.
31. Kuhns DB, DeCarlo E, Hawk DM, Gallin JI. Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest 1992; 89: 1734-40.